Editing Johnson & Johnson
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 80: | Line 80: | ||
==== ESG Highlights ==== | ==== ESG Highlights ==== | ||
Championing Global Health Equity | |||
• In 2022, we Ranked #2 in the Access to Medicine Index and were featured as an Index top-three performer for the sixth consecutive year, reflecting our decades-long deliberate and focused strategy to enable access to our innovative medicines and technologies. | • In 2022, we Ranked #2 in the Access to Medicine Index and were featured as an Index top-three performer for the sixth consecutive year, reflecting our decades-long deliberate and focused strategy to enable access to our innovative medicines and technologies. | ||
Line 92: | Line 92: | ||
• Through Our Race to Health Equity the $100 million, five-year initiative, by the end of 2022, Johnson & Johnson committed over $52 million in programs focused on closing the racial health gap, with investments in community health centers, community health workers, health literacy education and community engagement, increasing the racial and ethnic diversity of the health care talent pipeline and workforce. | • Through Our Race to Health Equity the $100 million, five-year initiative, by the end of 2022, Johnson & Johnson committed over $52 million in programs focused on closing the racial health gap, with investments in community health centers, community health workers, health literacy education and community engagement, increasing the racial and ethnic diversity of the health care talent pipeline and workforce. | ||
Empower our Employees | |||
• More than 130,000 employees (92%) responded to Our Credo Survey ― a testament to our values-driven culture. | • More than 130,000 employees (92%) responded to Our Credo Survey ― a testament to our values-driven culture. | ||
Line 104: | Line 104: | ||
• Enhanced mental health resources for employees and their families. | • Enhanced mental health resources for employees and their families. | ||
Advance Environmental Health | |||
• For the fifth consecutive year, Johnson & Johnson was recognized with a CDP A-List rating for our leadership in climate action. | • For the fifth consecutive year, Johnson & Johnson was recognized with a CDP A-List rating for our leadership in climate action. | ||
Line 116: | Line 116: | ||
• Expanded our U.S. Safe Returns program (pharma) to Switzerland with more countries planned for 2023. | • Expanded our U.S. Safe Returns program (pharma) to Switzerland with more countries planned for 2023. | ||
Lead with Accountability and Innovation | |||
• Included in the FTSE4Good Index Series for the 22nd year, which measures the performance of publicly traded companies demonstrating ESG practices, scoring in the 97th percentile in our sector in 2022. | • Included in the FTSE4Good Index Series for the 22nd year, which measures the performance of publicly traded companies demonstrating ESG practices, scoring in the 97th percentile in our sector in 2022. |